machine-learningarxiv

PeptSol: A Translational Benchmark for Protected-Peptide Solubility in Drug Manufacturing

Liquid-phase peptide synthesis (LPPS) offers a scalable route to peptide manufacturing, but route development still depends on empirical solvent screens because each protected intermediate must be…

Alexander Arjun Lobo / Marc Saouda / Urvi Awasthi / Leonid Zhukov

用途
原典で確認
難易度の目安
Hard
実装コストの目安
Medium

概要

Liquid-phase peptide synthesis (LPPS) offers a scalable route to peptide manufacturing, but route development still depends on empirical solvent screens because each protected intermediate must be soluble for reaction and recoverable for purification. The protecting groups, terminal modifications, and noncanonical residues that govern this behaviour are poorly represented in existing peptide property benchmarks, limiting the ability to develop and rigorously evaluate molecular representation models for LPPS-relevant prediction tasks. We introduce PeptSol, an open benchmark of 1388 hand-curated protected-peptide solubility measurements with chemistry-aware splits. The measurements span only 84 parent sequences and 101 protected structures, and 92.5% come from a single historical programme. Across seven frozen molecular encoders, the best macro-F1 is 0.843 on binary solubility for the historical subset under a peptide-held-out split; the harder three-class ordinal task reaches 0.614 in that cell. No foundation model consistently outperforms a baseline combining chemical fingerprints with explicit molecular descriptors, and model rankings vary across prediction tasks and data splits. The dataset, evaluation protocol, and baselines establish a standard for measuring progress on molecular representations for synthesis-aware peptide developability.

参考リンク

リンク先のライセンス・再現性・データ条件をご確認ください。自動分類や実装の目安は保証ではありません。

実装を始めるプロンプト

参考リンクを確認したうえで、次の内容をコピーして利用できます。

# 論文・記事
PeptSol: A Translational Benchmark for Protected-Peptide Solubility in Drug Manufacturing

# 概要
Liquid-phase peptide synthesis (LPPS) offers a scalable route to peptide manufacturing, but route development still depends on empirical solvent screens because each protected intermediate must be…

# 原典
https://arxiv.org/abs/2611.00749

上記の手法を実装してください。実行前に依存関係とライセンスを確認してください。

関連する記事